Teacher Retirement System Of Texas Anavex Life Sciences Corp. Transaction History

Teacher Retirement System Of Texas

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$4.55 - $6.75 $2,912 - $4,320	-640 Reduced 3.38%	18,268 $93,000
Q4 2023 Feb 07, 2024	SELL	$5.04 - $9.95 $19,963 - $39,411	-3,961 Reduced 17.32%	18,908 $176,000
Q3 2023 Oct 31, 2023	BUY	$6.55 - $9.37 $8,364 - $11,965	1,277 Added 5.91%	22,869 $150,000
Q2 2023 Jul 19, 2023	SELL	$7.66 - $9.5 $18,575 - $23,037	-2,425 Reduced 10.1%	21,592 $176,000
Q1 2023 May 12, 2023	SELL	$8.32 - $11.75 $74 - $105	-9 Reduced 0.04%	24,017 $206,000
Q4 2022 Feb 10, 2023	SELL	$7.65 - $14.43 $10,381 - $19,581	-1,357 Reduced 5.35%	24,026 $222,000
Q3 2022 Nov 03, 2022	BUY	$8.9 - $12.86 $123,184 - $177,995	13,841 Added 119.92%	25,383 $262,000
Q2 2022 Aug 09, 2022	SELL	$7.31 - $12.84 $23,984 - $42,128	-3,281 Reduced 22.13%	11,542 $116,000
Q1 2022 May 09, 2022	BUY	$9.74 - $17.69 $7,694 - $13,975	790 Added 5.63%	14,823 $182,000
Q4 2021 Feb 10, 2022	BUY	$16.88 - $23.31 $65,983 - $91,118	3,909 Added 38.61%	14,033 $243,000
Q3 2021 Nov 09, 2021	BUY	$16.82 - $25.75 $170,285 - $260,693	10,124 New	10,124 $182,000

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.